Copyright Nasdaq. Minimum 15 minutes delayed.

Investor FAQs

Where is Immunovaccine located?

#53, 1344 Summer Street, Suite 412
Halifax, Nova Scotia, Canada
B3H 0A8

Telephone: (902) 492-1819
Facsimile: (902) 492-0888

When was Immunovaccine founded?

March 28, 2000

When did Immunovaccine go public and at what price?

Immunovaccine started trading on the TSX-Venture Exchange in Canada on October 5, 2009, under the ticker symbol “IMV”. The initial public offering was done at share price $0.70 per share. The Company graduated to the Toronto Stock Exchange on November 26, 2014.

On what stock exchange and under what symbol are Immunovaccine shares traded?


How can I invest in Immunovaccine?

Click here for Investor Relations inquiries.

Who are Immunovaccine’s independent auditors?

PricewaterhouseCoopers LLP (PWC)
1601 Lower Water St #400, Halifax, NS B3J 3P6, 902-491-7400

Who is Immunovaccine’s outside legal counsel?

McCarthy Tétrault LLP
9e étage, 500 Grande Allée E, Québec City, Québec G1R 2J7, 418-521-3000

Who acts as transfer agent for Immunovaccine common stock?

Computershare Investor Services Inc.
100 University Avenue, 8th Floor, Toronto, Ontario M5J 2Y1, 416-263-9200

What is Immunovaccine’s fiscal year?

Our FYE is December 31.

Who are the financial analysts that follow Immunovaccine?

Click here to see the analysts that follow Immunovaccine.

Who are the members of Immunovaccine's Board of Directors?

Click here to see the Immunovaccine Board of Directors.

How can I contact Immunovaccine regarding Investor Relations?

Contact our IR Department here.